Literature DB >> 11162977

Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.

B Yazici1, Z Yazici, M Parlak.   

Abstract

PURPOSE: To evaluate the efficacy of polyurethane nasolacrimal duct stents in the treatment of epiphora resulting from primary acquired nasolacrimal duct obstruction in adults.
MATERIALS AND METHODS: In 25 patients (21 women and four men with mean age of 44 years, range 20 to 74 years) with nasolacrimal duct obstruction, 28 hollow polyurethane stents designed by Song and associates were placed under fluoroscopic guidance. The obstruction was complete in 20 lacrimal drainage systems and partial in eight. The lacrimal sac size was normal or large on dacryocystogram in all lacrimal drainage systems. A Ritleng probe was introduced through the upper punctum and advanced past the obstruction. A guide wire with a flexible tip was then introduced through the probe, over which the stent was advanced in retrograde fashion and placed into the lacrimal sac and nasolacrimal duct. Clinical success was defined by the demonstration of a completely patent lacrimal drainage pathway through saline irrigation and no or minimal complaint of epiphora.
RESULTS: Stent placement was technically successful in 26 of 28 lacrimal drainage systems (93%). The mean time of fluoroscopy screening was 3.2 minutes (range, 1.4 to 5.8 minutes). The overall success rate was 82% (23 of 28 lacrimal drainage systems). Two stents were completely occluded. In one lacrimal drainage system with minimal epiphora, the stented drainage pathway was partially occluded. The patients were followed up from 4 to 22 months (mean, 7.2 months).
CONCLUSIONS: Retrograde placement of a hollow polyurethane nasolacrimal duct stent is a technique that is simple and well tolerated by patients. This method achieves a high success rate and may be suggested as a nonsurgical procedure for adults with primary nasolacrimal duct obstruction and proper lacrimal sac size. The Ritleng probe facilitates the procedure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162977     DOI: 10.1016/s0002-9394(00)00702-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  [Balloon dilatation and Stentimplantation of the nasolacrimal duct for chronic epiphora].

Authors:  U Lachmund; D Ammann-Rauch; A Forrer; M Grob; C Petralli; L Remonda; T Roeren; K Wilhelm
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

2.  Polyurethane stents for lacrimal duct stenoses: 5-year results.

Authors:  Eckart Bertelmann; Peter Rieck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-21       Impact factor: 3.117

3.  Polyurethane stent obstruction as a cause of recurrent epiphora. Case report.

Authors:  S Doganay; K Sarac; M C Miman; N Karadag; Y Cokkeser
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

4.  The results of Ritleng bicanalicular silicone intubation for congenital and adult partially acquired nasolacrimal duct obstruction.

Authors:  Sevda Aydin Kurna; Tomris Sengor; Murat Garli
Journal:  North Clin Istanb       Date:  2021-10-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.